- From: Matt Williams <matthew.williams@cancer.org.uk>
- Date: Thu, 04 Oct 2007 22:23:25 +0100
- To: Susie Stephens <susie.stephens@gmail.com>
- CC: Daniel Rubin <rubin@med.stanford.edu>, public-semweb-lifesci hcls <public-semweb-lifesci@w3.org>
If work goes well tomorrow, perhaps. Else perhaps Monday pm. Daniel - can we divide this sensibly? Matt Susie Stephens wrote: > Hi Matt, Daniel, > > It would be great if you were able to write a brief description of the > data set, list the terms that are used, and also provide some > information as to how the data is currently used. > > Would it be realistic for either of you to get that done by Monday? > > Cheers, > > Susie > > > > On 10/4/07, *Daniel Rubin* <rubin@med.stanford.edu > <mailto:rubin@med.stanford.edu>> wrote: > > I might be able to help look as some of these data, depending on > what specifically is expected for this task. > > Regards, > > Daniel > > ___ > > Daniel Rubin, MD, MS > Clinical Asst. Professor, Radiology > Research Scientist, Stanford Medical Informatics > Scientific Director, National Center of Biomedical Ontology > MSOB X-215 > Stanford, CA 94305 > 650-725-5693 > > > > > At 09:16 AM 10/4/2007, Susie Stephens wrote: >> Assessing clinical data sets for incorporation into our work >> sounds like an excellent idea. I'll add that as an agenda item for >> Monday's BioRDF call as suggested by EricN. >> >> It would be wonderful is someone wants to volunteer to take a look >> at the cancer data set that Alan uncovered ( >> <http://seer.cancer.gov/data/> http://seer.cancer.gov/data/). If >> someone has the bandwidth by Monday then that would be great, but >> providing feedback the week after would also be excellent. >> >> Another data set that I think is interesting is the one being >> developed by the Alzheimers Disease NeuroImaging Initiative ( >> http://www.loni.ucla.edu/ADNI/). This is an open data set that >> includes serial magnetic resonance imaging (MRI), positron >> emission tomography (PET), other biological markers, and clinical >> and neuropsychological assessment data. The goal of the data is to >> use it to learn about the progression of mild cognitive impairment >> and early Alzheimer's disease. I'm definitely going to be >> exploring this data further, but I'd be more than happy for other >> folks to take a look at it too. >> >> Cheers, >> >> Susie >> >> >> >> >> >> >> >> On 10/4/07, *Eric Neumann* <eneumann@teranode.com >> <mailto:eneumann@teranode.com>> wrote: >> >> >> Indeed this would be an interesting set to rdf-ize. It might >> also be interesting based on the dataset complexity (i.e., >> moderate complexity) to see what practical stratgey for RDF >> conversion one would choose. >> >> http://seer.cancer.gov/data/ >> >> Perhaps a few folks could look at this data structure, >> consider some approaches ( e.g., RDF-Schema only vs. a minimal >> ontology), and discuss this on the next BioRDF call? >> >> Eric >> >> >> >> -----Original Message----- >> From: public-semweb-lifesci-request@w3.org >> <mailto:public-semweb-lifesci-request@w3.org> on behalf of >> Alan Ruttenberg >> Sent: Wed 10/3/2007 1:07 AM >> To: public-semweb-lifesci hcls >> Subject: Surveillance Epidemiology and End Results (SEER) >> >> >> At a talk I attended today, this resource of patient cancer >> diagnoses >> was mentioned as an example of publicly available clinical >> data. A >> quick look over the documentation suggests it might be an >> interesting >> project to produce an RDF version of the data set. >> >> http://seer.cancer.gov/data/ >> >> The SEER limited-use data* include SEER incidence and >> population data >> associated by age, sex, race, year of diagnosis, and >> geographic areas >> (including SEER registry and county) >> >> -Alan >> >> >> > -- http://acl.icnet.uk/~mw http://adhominem.blogsome.com/ +44 (0)7834 899570
Received on Thursday, 4 October 2007 21:24:04 UTC